Marilyn Mora
Family · Tucson, AZNPI 1821544032
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 674 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 31 manufacturers reported payments, led by Amgen at 24.0% of the total. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 674 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$3K
- AbbVie$3K
- UCB, Inc.$1K
- Pfizer$801
- Lilly USA, LLC$610
- Johnson & Johnson$435
- plus $3K from 25 others
What the payments were for
- Food & beverage$12,21999%
- Education$961%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen(2 entities) | 181 | $2,956 |
| AbbVie | 154 | $2,845 |
| UCB, Inc. | 56 | $1,495 |
| Pfizer | 55 | $801 |
| Lilly USA, LLC | 25 | $610 |
| Johnson & Johnson(2 entities) | 48 | $435 |
| GSK | 26 | $429 |
| Organon | 18 | $362 |
| Radius Health, Inc. | 16 | $336 |
| AstraZeneca(2 entities) | 18 | $301 |
| Sanofi | 11 | $278 |
| Mallinckrodt Hospital Products Inc. | 9 | $241 |
| Boehringer Ingelheim | 10 | $236 |
| E.r. Squibb & Sons, L.L.C. | 7 | $143 |
| Ferring Pharmaceuticals Inc. | 7 | $118 |
| Sobi, Inc | 3 | $95 |
| Fresenius Kabi USA, LLC | 3 | $74 |
| Genentech USA, Inc. | 3 | $65 |
| Aurinia Pharma U.S., Inc. | 3 | $58 |
| ANI Pharmaceuticals, Inc. | 3 | $56 |
| Novartis | 3 | $56 |
| Kyowa Kirin, Inc. | 2 | $54 |
| Teva Pharmaceuticals USA, Inc. | 3 | $51 |
| Actelion Pharmaceuticals US, Inc. | 3 | $51 |
| Kiniksa Pharmaceuticals International, PLC | 1 | $40 |
| Biogen | 1 | $29 |
| Celltrion USA Inc. | 1 | $26 |
| Octapharma USA, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $19 |
| Mylan Institutional Inc. | 1 | $17 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $16 |
How this compares
$12,315 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira(Cf) PenAdalimumab | 13 | $138,356 |
| Enbrel SureclickEtanercept | 17 | $135,867 |
| Hydroxychloroquine Sulfate | 458 | $16,304 |
| Leflunomide | 128 | $9,965 |
| MethotrexateMethotrexate Sodium | 333 | $4,124 |
| Pilocarpine Hcl | 36 | $2,581 |
| Sulfasalazine DrSulfasalazine | 56 | $2,088 |
| Colchicine | 18 | $2,042 |
| Prednisone | 343 | $1,770 |
| Azathioprine | 30 | $960 |
| Sulfasalazine | 27 | $912 |
| Folic Acid | 74 | $801 |
| Duloxetine Hcl | 41 | $581 |
| Triamcinolone Acetonide | 11 | $448 |
| Allopurinol | 38 | $435 |
Paid to pharmacies, not to this prescriber.
Other family in Tucson
- Lindsay CarterTucson$108K
- Vicki McIntyreTucson$68K
- Amber KemnitzTucson$33K
- Joy BaynesTucson$30K
- Cynthia CarstenTucson$27K
- Sharon MorganTucson$22K
- Margaret SpencerTucson$19K
- Polina SamoylovaTucson$18K
- Stephanie Niemi-OlsonTucson$15K
- Cindy ChangTucson$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.